Here’s what you should know:
1. Five analyst firms made predictions on Valeant’s quarterly sales, the lowest estimate was $2.09 billion, while the highest was $2.24 billion.
2. If the estimates are correct, it shows Valeant sales decreased 9.6 percent year over year.
3. Valeant will announce its quarterly earnings Feb. 27.
4. Analysts anticipate full-year sales between $8.65 billion to $8.80 billion.
More articles on supply chain:
Campbell Clinic receives 8-year tax abatement for $30M expansion with ASC — 4 insights
Maximize your 2018 reimbursements: Know your health plans, know your market, and stay on top of trends
21 statistics on ASC accounts receivable
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.